SRA
Summit Rock Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-51,502
| Closed | -$851K | – | 9 |
|
|
2024
Q1 | $851K | Buy |
+51,502
| New | +$851K | 0.27% | 9 |
|
|
2022
Q4 | – | Sell |
-25,751
| Closed | -$516K | – | 3 |
|
|
2022
Q3 | $516K | Sell |
25,751
-7,374
| -22% | -$148K | 0.4% | 5 |
|
|
2022
Q2 | $593K | Hold |
33,125
| – | – | 0.48% | 5 |
|
|
2022
Q1 | $329K | Hold |
33,125
| – | – | 0.2% | 7 |
|
|
2021
Q4 | $558K | Buy |
+33,125
| New | +$558K | 0.33% | 6 |
|